STARHEALTH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | STARHEALTH | Market Cap | 30,794 Cr. | Current Price | 523 ₹ | High / Low | 587 ₹ |
| Stock P/E | 55.3 | Book Value | 163 ₹ | Dividend Yield | 0.00 % | ROCE | 8.57 % |
| ROE | 6.70 % | Face Value | 10.0 ₹ | DMA 50 | 499 ₹ | DMA 200 | 474 ₹ |
| Chg in FII Hold | 0.99 % | Chg in DII Hold | -0.65 % | PAT Qtr | 111 Cr. | PAT Prev Qtr | 128 Cr. |
| RSI | 61.3 | MACD | 7.46 | Volume | 4,13,797 | Avg Vol 1Wk | 8,55,846 |
| Low price | 413 ₹ | High price | 587 ₹ | PEG Ratio | -16.0 | Debt to equity | 0.05 |
| 52w Index | 63.6 % | Qtr Profit Var | 21,731 % | EPS | 9.47 ₹ | Industry PE | 42.7 |
📊 STARHEALTH shows moderate intraday potential. RSI at 61.3 indicates bullish momentum but not yet overbought. MACD (7.46) is positive, suggesting upward bias. Current price (523 ₹) is above both 50 DMA (499 ₹) and 200 DMA (474 ₹), reflecting short-term and medium-term strength. Volume (4.13L) is lower than the 1-week average (8.55L), showing reduced participation today.
💡 Optimal Buy Price: 518–523 ₹ (near support)
🎯 Profit-Taking Levels: 540–550 ₹ (resistance zone)
🛑 Stop-Loss: 510 ₹ (below support)
⏱ If already holding: Exit near 540–550 ₹ if momentum weakens or volume fails to sustain. If price breaks below 510 ₹ with strong selling pressure, consider intraday exit to protect capital.
Positive
- ✅ EPS at 9.47 ₹ reflects earnings growth
- ✅ Price trading above both 50 DMA and 200 DMA
- ✅ FII holding increased (+0.99%), showing foreign investor confidence
Limitation
- ⚠️ High P/E ratio of 55.3 compared to industry average (42.7)
- ⚠️ ROE at 6.70% and ROCE at 8.57% are modest
- ⚠️ PEG ratio at -16.0 indicates valuation concerns
- ⚠️ Volume below average, limiting intraday momentum
Company Negative News
- 📉 Decline in DII holding (-0.65%) shows reduced domestic institutional support
- 📉 PAT declined (128 Cr → 111 Cr)
Company Positive News
- 📈 Quarterly profit variation at +21,731% indicates strong recovery from prior losses
- 📈 Price strength supported by technical levels above DMA
Industry
- 🏭 Industry PE at 42.7 vs STARHEALTH PE at 55.3 shows overvaluation
- 🏭 Insurance sector remains growth-oriented with rising demand for health coverage
Conclusion
⚖️ STARHEALTH offers moderate intraday trading potential with bullish signals from RSI, MACD, and price strength above key moving averages. Traders may attempt entries near 518–523 ₹ with profit targets around 540–550 ₹. However, high valuation, weak ROE/ROCE, and declining PAT suggest cautious positioning with strict stop-losses.
Would you like me to extend this into a swing trade analysis for medium-term clarity, or refine the intraday trading plan further?